Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-30 4:09 pm Purchase |
2025-01-23 | 13G | Arvinas, Inc. ARVN |
Citadel Advisors LLC | 3,480,125 5.100% |
3,480,125 (New Position) |
Filing History |
| 2024-12-13 5:02 pm Purchase |
2024-12-06 | 13G | Nkarta, Inc. NKTX |
Citadel Advisors LLC | 3,819,867 5.400% |
3,819,867 (New Position) |
Filing History |
| 2024-11-14 4:24 pm Sale |
2024-09-30 | 13G | Enliven Therapeutics, Inc. ELVN |
Citadel Advisors LLC | 1,734,094 3.700% |
-660,354 (-27.58%) |
Filing History |
| 2024-11-14 4:23 pm Sale |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,960,081 3.000% |
-112,506 (-3.66%) |
Filing History |
| 2024-11-14 4:21 pm Sale |
2024-09-30 | 13G | Dutch Bros Inc. BROS |
Citadel Advisors LLC | 2,974,719 2.600% |
-1,099,167 (-26.98%) |
Filing History |
| 2024-11-14 4:20 pm Purchase |
2024-09-30 | 13G | COMPASS Pathways plc CMPS |
Citadel Advisors LLC | 5,434,676 8.000% |
2,239,159 (+70.07%) |
Filing History |
| 2024-11-14 4:20 pm Sale |
2024-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Citadel Advisors LLC | 2,737,221 3.900% |
-1,001,261 (-26.78%) |
Filing History |
| 2024-11-14 4:19 pm Sale |
2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN |
Citadel Advisors LLC | 1,158,219 4.200% |
-442,549 (-27.65%) |
Filing History |
| 2024-11-14 4:19 pm Sale |
2024-09-30 | 13G | Vigil Neuroscience, Inc. VIGL |
Citadel Advisors LLC | 1,442,489 3.600% |
-719,413 (-33.28%) |
Filing History |
| 2024-11-14 4:19 pm Sale |
2024-09-30 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 0 0.000% |
-2,458,958 (Position Closed) |
Filing History |
| 2024-11-14 4:18 pm Sale |
2024-09-30 | 13G | UWM Holdings Corporation UWMC |
Citadel Advisors LLC | 8,995,096 7.900% |
-17,254 (-0.19%) |
Filing History |
| 2024-11-14 4:18 pm Sale |
2024-09-30 | 13G | Aura Biosciences, Inc. AURA |
Citadel Advisors LLC | 32,626 0.100% |
-3,598,868 (-99.10%) |
Filing History |
| 2024-11-14 4:18 pm Sale |
2024-09-30 | 13G | REV Group, Inc. REVG |
Citadel Advisors LLC | 1,336,604 2.600% |
-1,360,669 (-50.45%) |
Filing History |
| 2024-11-14 4:17 pm Sale |
2024-09-30 | 13G | NETSTREIT Corp. NTST |
Citadel Advisors LLC | 611,297 0.800% |
-3,496,902 (-85.12%) |
Filing History |
| 2024-11-14 4:17 pm Purchase |
2024-09-30 | 13G | Atara Biotherapeutics, Inc. ATRA |
Citadel Advisors LLC | 260,480 4.600% |
260,480 (New Position) |
Filing History |
| 2024-11-14 4:17 pm Sale |
2024-09-30 | 13G | Janux Therapeutics, Inc. JANX |
Citadel Advisors LLC | 1,021,403 2.000% |
-2,104,494 (-67.32%) |
Filing History |
| 2024-11-14 4:16 pm Sale |
2024-09-30 | 13G | AN2 Therapeutics, Inc. ANTX |
Citadel Advisors LLC | 22 0.000% |
-1,556,820 (-100.00%) |
Filing History |
| 2024-11-14 4:15 pm Sale |
2024-09-30 | 13G | Allurion Technologies Inc. ALUR |
Citadel Advisors LLC | 4,004 0.200% |
-98,545 (-96.10%) |
Filing History |
| 2024-11-14 4:15 pm Sale |
2024-09-30 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,672 0.000% |
-2,075,420 (-99.87%) |
Filing History |
| 2024-11-14 4:14 pm Sale |
2024-09-30 | 13G | Aclaris Therapeutics, Inc. ACRS |
Citadel Advisors LLC | 368,067 0.500% |
-5,038,022 (-93.19%) |
Filing History |